Financhill
Sell
40

LUMN Quote, Financials, Valuation and Earnings

Last price:
$7.77
Seasonality move :
1.54%
Day range:
$7.64 - $7.94
52-week range:
$3.01 - $11.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.61x
P/B ratio:
13.17x
Volume:
11.3M
Avg. volume:
14.1M
1-year change:
33.51%
Market cap:
$8B
Revenue:
$13.1B
EPS (TTM):
-$1.66
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $20.7B $19.7B $17.5B $14.6B $13.1B
Revenue Growth (YoY) -3.48% -4.95% -11.22% -16.71% -9.95%
 
Cost of Revenues $13.8B $12.7B $11.1B $10.1B $9.7B
Gross Profit $6.9B $7B $6.4B $4.4B $3.4B
Gross Profit Margin 33.42% 35.41% 36.45% 30.42% 26.31%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.5B $2.9B $3.1B $3.2B $3B
Other Inc / (Exp) -$2.7B -$62M -$3B -$10.4B $546M
Operating Expenses $3.3B $2.7B $3.1B $3.2B $3B
Operating Income $3.6B $4.3B $3.3B $1.2B $477M
 
Net Interest Expenses $1.6B $1.4B $1.3B $1.2B $1.4B
EBT. Incl. Unusual Items -$782M $2.7B -$991M -$10.2B -$230M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $450M $668M $557M $61M -$175M
Net Income to Company -$1.2B $2B -$1.5B -$10.3B -$55M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.2B $2B -$1.5B -$10.3B -$55M
 
Basic EPS (Cont. Ops) -$1.14 $1.92 -$1.54 -$10.48 -$0.06
Diluted EPS (Cont. Ops) -$1.14 $1.91 -$1.54 -$10.48 -$0.06
Weighted Average Basic Share $1.1B $1.1B $1B $983.1M $987.7M
Weighted Average Diluted Share $1.1B $1.1B $1B $983.1M $987.7M
 
EBITDA $8.7B $8.7B $6.5B $4.2B $3.4B
EBIT $3.6B $4.3B $3.3B $1.2B $477M
 
Revenue (Reported) $20.7B $19.7B $17.5B $14.6B $13.1B
Operating Income (Reported) $3.6B $4.3B $3.3B $1.2B $477M
Operating Income (Adjusted) $3.6B $4.3B $3.3B $1.2B $477M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $4.9B $4.4B $3.6B $3.2B $3.1B
Revenue Growth (YoY) -5.42% -10.17% -17.06% -11.54% -4.16%
 
Cost of Revenues $3.1B $2.8B $2.6B $2.4B $2.4B
Gross Profit $1.7B $1.5B $1B $822M $713M
Gross Profit Margin 35.77% 35.26% 28.45% 25.52% 23.1%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $654M $792M $791M $696M $829M
Other Inc / (Exp) -$38M $509M -$39M $35M --
Operating Expenses $617M $757M $791M $696M $829M
Operating Income $1.1B $791M $245M $126M -$116M
 
Net Interest Expenses $356M $363M $295M $351M $319M
EBT. Incl. Unusual Items $716M $937M -$85M -$172M -$813M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $172M $359M -$7M -$24M -$192M
Net Income to Company $544M $578M -$78M -$148M -$621M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $544M $578M -$78M -$148M -$621M
 
Basic EPS (Cont. Ops) $0.51 $0.57 -$0.08 -$0.15 -$0.62
Diluted EPS (Cont. Ops) $0.51 $0.57 -$0.08 -$0.15 -$0.62
Weighted Average Basic Share $1.1B $1B $983.6M $988.8M $996M
Weighted Average Diluted Share $1.1B $1B $983.6M $988.8M $996M
 
EBITDA $2.2B $1.7B $1B $833M $558M
EBIT $1.1B $791M $245M $126M -$116M
 
Revenue (Reported) $4.9B $4.4B $3.6B $3.2B $3.1B
Operating Income (Reported) $1.1B $791M $245M $126M -$116M
Operating Income (Adjusted) $1.1B $791M $245M $126M -$116M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $20B $18.5B $14.8B $13.3B $12.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $13.1B $11.6B $10.3B $9.7B $9.6B
Gross Profit $6.9B $6.9B $4.5B $3.6B $3.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3B $3.1B $3B $3.2B $3B
Other Inc / (Exp) -$2.6B $347M -$11.8B -$1.5B --
Operating Expenses $2.9B $3B $2.9B $3.2B $3B
Operating Income $4B $3.9B $1.6B $456M $170M
 
Net Interest Expenses $1.5B $1.4B $1.1B $1.3B $1.4B
EBT. Incl. Unusual Items -$186M $2.9B -$11.3B -$2.3B -$2.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $578M $841M $95M -$118M -$674M
Net Income to Company -$764M $2B -$11.4B -$2.1B -$1.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$764M $2B -$11.4B -$2.1B -$1.7B
 
Basic EPS (Cont. Ops) -$0.70 $2.01 -$11.52 -$2.17 -$1.66
Diluted EPS (Cont. Ops) -$0.71 $2.00 -$11.52 -$2.17 -$1.66
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $8.7B $7.6B $4.8B $3.4B $3B
EBIT $4B $3.9B $1.6B $456M $170M
 
Revenue (Reported) $20B $18.5B $14.8B $13.3B $12.7B
Operating Income (Reported) $4B $3.9B $1.6B $456M $170M
Operating Income (Adjusted) $4B $3.9B $1.6B $456M $170M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $14.8B $13.7B $11B $9.8B $9.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.7B $8.6B $7.7B $7.2B $7.1B
Gross Profit $5.2B $5.1B $3.3B $2.6B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B $2.4B $2.3B $2.3B $2.3B
Other Inc / (Exp) $24M $457M -$8.3B $491M -$882M
Operating Expenses $2.1B $2.3B $2.2B $2.3B $2.3B
Operating Income $3.1B $2.8B $1.1B $323M $16M
 
Net Interest Expenses $1.1B $1B $868M $1B $1B
EBT. Incl. Unusual Items $2B $2.2B -$8.1B -$111M -$2.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $497M $670M $208M $29M -$470M
Net Income to Company $1.5B $1.5B -$8.3B -$140M -$1.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.5B $1.5B -$8.3B -$140M -$1.7B
 
Basic EPS (Cont. Ops) $1.42 $1.50 -$8.44 -$0.14 -$1.75
Diluted EPS (Cont. Ops) $1.41 $1.50 -$8.44 -$0.14 -$1.75
Weighted Average Basic Share $3.2B $3B $2.9B $3B $3B
Weighted Average Diluted Share $3.3B $3B $2.9B $3B $3B
 
EBITDA $6.5B $5.5B $3.5B $2.5B $2.1B
EBIT $3.1B $2.8B $1.1B $323M $16M
 
Revenue (Reported) $14.8B $13.7B $11B $9.8B $9.4B
Operating Income (Reported) $3.1B $2.8B $1.1B $323M $16M
Operating Income (Adjusted) $3.1B $2.8B $1.1B $323M $16M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $409M $356M $1.3B $2.2B $1.9B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.9B $1.6B $1.4B $1.3B $1.2B
Inventory $105M $96M $236M $209M $146M
Prepaid Expenses $290M $295M $319M $395M $372M
Other Current Assets $53M $11M $5M $14M $22M
Total Current Assets $2.9B $11.3B $5.2B $4.6B $4.2B
 
Property Plant And Equipment $28B $20.9B $19.2B $19.8B $20.4B
Long-Term Investments -- $13M $12M $10M $9M
Goodwill $18.9B $16B $12.7B $2B $2B
Other Intangibles $8.2B $7B $6.2B $5.5B $4.8B
Other Long-Term Assets $2.8B $2.6B $2.2B $2.1B $1.9B
Total Assets $59.4B $58B $45.6B $34B $33.5B
 
Accounts Payable $805M $758M $1B $1.1B $749M
Accrued Expenses $1.3B $1.1B $873M $864M $913M
Current Portion Of Long-Term Debt $2.4B $1.6B $154M $157M $412M
Current Portion Of Capital Lease Obligations $379M $385M $344M $268M $253M
Other Current Liabilities $328M $2.5B $728M $213M $179M
Total Current Liabilities $6.6B $7.2B $4.9B $3.5B $3.6B
 
Long-Term Debt $30.8B $28.6B $21.5B $20.9B $18.5B
Capital Leases -- -- -- -- --
Total Liabilities $48.2B $46.2B $35.2B $33.6B $33B
 
Common Stock $1.1B $1B $1B $1B $19.1B
Other Common Equity Adj -$2.8B -$2.2B -$1.1B -$810M -$723M
Common Equity $11.2B $11.8B $10.4B $417M $464M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $11.2B $11.8B $10.4B $417M $464M
 
Total Liabilities and Equity $59.4B $58B $45.6B $34B $33.5B
Cash and Short Terms $409M $356M $1.3B $2.2B $1.9B
Total Debt $33.2B $30.2B $21.7B $21B $18.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $637M $253M $311M $2.6B $2.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.6B $1.5B $1.4B $1.2B $1.3B
Inventory $103M $179M $227M $173M $163M
Prepaid Expenses $294M $371M $392M $357M $370M
Other Current Assets $22M $14M $15M $19M --
Total Current Assets $11.5B $9.1B $4.4B $4.5B $8.5B
 
Property Plant And Equipment $20.9B $20.7B $19.6B $20.3B $19.1B
Long-Term Investments $28M $12M $11M $11M $8M
Goodwill $16B $15.9B $3.9B $2B --
Other Intangibles $7.2B $6.4B $5.7B $5B --
Other Long-Term Assets $2.5B $2.4B $2.1B $2B --
Total Assets $58.3B $54.8B $35.9B $34B $34.3B
 
Accounts Payable $829M $1B $1B $905M $1.1B
Accrued Expenses $1.1B $972M $872M $936M --
Current Portion Of Long-Term Debt $2.5B $3.5B $155M $415M --
Current Portion Of Capital Lease Obligations $389M $396M $296M $263M --
Other Current Liabilities $2.6B $2B $652M $179M --
Total Current Liabilities $8.3B $8.7B $3.9B $3.9B $3.9B
 
Long-Term Debt $27.3B $21.8B $19.7B $18.1B $17.6B
Capital Leases -- -- -- -- --
Total Liabilities $47.1B $42.2B $33.7B $33.6B $35.5B
 
Common Stock $1B $1B $1B $1B $19.2B
Other Common Equity Adj -$2.6B -$2.2B -$1.1B -$766M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $11.2B $12.6B $2.2B $342M -$1.2B
 
Total Liabilities and Equity $58.3B $54.8B $35.9B $34B $34.3B
Cash and Short Terms $637M $253M $311M $2.6B $2.4B
Total Debt $29.8B $25.2B $19.9B $18.6B $17.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$1.2B $2B -$1.5B -$10.3B -$55M
Depreciation & Amoritzation $4.7B $4B $3.2B $3B $3B
Stock-Based Compensation $175M $120M $98M $52M $29M
Change in Accounts Receivable $115M -$8M -$158M $102M $19M
Change in Inventories -- -- -- -- --
Cash From Operations $6.5B $6.5B $4.7B $2.2B $4.3B
 
Capital Expenditures $3.7B $2.9B $3B $3.1B $3.2B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.6B -$2.7B $5.5B -$1.2B -$2.8B
 
Dividends Paid (Ex Special Dividend) $1.1B $1.1B $780M $11M $3M
Special Dividend Paid
Long-Term Debt Issued $4.4B $1.9B -- -- $1.3B
Long-Term Debt Repaid -$7.3B -$3.6B -$8.1B -$185M -$2.7B
Repurchase of Common Stock -- $1B $200M -- --
Other Financing Activities -$87M -$53M -$40M -$22M -$295M
Cash From Financing -$4.3B -$3.8B -$9.3B -$18M -$1.9B
 
Beginning Cash (CF) $409M $356M $1.3B $2.2B $1.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.3B -$18M $898M $941M -$348M
Ending Cash (CF) -$881M $338M $2.1B $3.2B $1.5B
 
Levered Free Cash Flow $2.8B $3.6B $1.7B -$940M $1.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $544M $578M -$78M -$148M -$621M
Depreciation & Amoritzation $951M $808M $755M $707M $674M
Stock-Based Compensation $27M $23M $16M $10M $13M
Change in Accounts Receivable $16M -$59M $39M $54M -$12M
Change in Inventories -- -- -- -- --
Cash From Operations $1.7B $1.1B $9.7B $2B $2.5B
 
Capital Expenditures $690M $845M $843M $850M $1B
Cash Acquisitions -- -- -- -$5M --
Cash From Investing -$654M $1.9B -$827M -$805M -$1B
 
Dividends Paid (Ex Special Dividend) $266M $255M $1M -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -$600M -$200M -- --
Long-Term Debt Repaid $10M -$2.4B -$45M $128M --
Repurchase of Common Stock $909M -- -- -- --
Other Financing Activities -$3M -$1M -$2M -$6M --
Cash From Financing -$1.3B -$3.1B -$173M -$81M -$651M
 
Beginning Cash (CF) $637M $253M $311M $2.6B $2.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$242M -$156M -$119M $1.1B $833M
Ending Cash (CF) $395M $97M $192M $3.8B $3.2B
 
Levered Free Cash Flow $1B $278M $8.8B $1.2B $1.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$764M $2B -$11.4B -$2.1B -$1.7B
Depreciation & Amoritzation $4.3B $3.3B $3B $2.9B $2.8B
Stock-Based Compensation $144M $102M $66M $34M $43M
Change in Accounts Receivable $169M -$55M -$128M $138M -$112M
Change in Inventories -- -- -- -- --
Cash From Operations $6.6B $5.5B $2.2B $4.4B $4.9B
 
Capital Expenditures $2.8B $3B $3.1B $3.1B $3.6B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.7B -$169M $2.7B -$968M -$3.5B
 
Dividends Paid (Ex Special Dividend) $1.1B $1B $10M $4M --
Special Dividend Paid
Long-Term Debt Issued $3B -- -- $1.3B --
Long-Term Debt Repaid -$3.6B -$4.9B -$4.3B -$2.1B --
Repurchase of Common Stock $909M $91M $200M -- --
Other Financing Activities -$56M -$34M -$28M -$295M --
Cash From Financing -$3.7B -$5.8B -$4.8B -$1.2B -$1.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $157M -$439M $85M $2.3B -$241M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $3.8B $2.5B -$895M $1.3B $1.2B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.5B $1.5B -$8.3B -$140M -$1.7B
Depreciation & Amoritzation $3.1B $2.4B $2.2B $2.2B $2.1B
Stock-Based Compensation $89M $71M $39M $21M $35M
Change in Accounts Receivable $20M -$27M $3M $39M -$92M
Change in Inventories -- -- -- -- --
Cash From Operations $4.9B $3.9B $1.4B $3.6B $4.2B
 
Capital Expenditures $2.1B $2.2B $2.3B $2.3B $2.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.9B $594M -$2.2B -$2B -$2.7B
 
Dividends Paid (Ex Special Dividend) $834M $780M $10M $3M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.9B -- -- $1.3B $4.3B
Long-Term Debt Repaid -$2.6B -$3.9B -$145M -$2.1B -$4.3B
Repurchase of Common Stock $909M -- -- -- --
Other Financing Activities -$52M -$33M -$21M -$294M -$321M
Cash From Financing -$2.7B -$4.6B -$101M -$1.2B -$995M
 
Beginning Cash (CF) $2.1B $982M $1.9B $5.7B $5.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $277M -$144M -$957M $405M $512M
Ending Cash (CF) $2.3B $838M $913M $6.1B $6.4B
 
Levered Free Cash Flow $2.8B $1.7B -$903M $1.3B $1.5B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock